Education/Training and Outreach Activities

教育/培训和外展活动

基本信息

项目摘要

NSBCC education & training programs are designed to bring cancer researchers together with physical scientists and technologists in order to expedite the develoment of new and effective tools for fighting cancer. Our goal is to have student and postdoctoral researchers who understand the cancer biology or clinical oncology problem, can participate in technology invention, development, and validation, and then can demonstrate the value of the technology in pre-clinical settings and hopefully via participation in human studies. We describe one-on-one mentorship programs within our individual projects designed to bothfacilitate such training, but also catalyze the collaboratory effort. We also describe three NSBCC short courses, taught at each of the participating institutions, that are designed to teach our researchers key fundamental aspects associated with NSBCC-developed technologies, as well as NSBCC ongoing projects. These courses, designed for non-specialists, are complemented with in depth courses designed for more specialist students that are offered at the participating institutions. We also describe internal educational activities that include student and postdoc participation in our annual retreat, biweekly NSBCC Project meetings, site reviews and national CCNE meetings. Mechanisms to facilitate intra- and inter-CCNE collaborations. The educational programs are overseen by our Internal Review Council and annually reviewed by our External Advisory Board. Outreach programs to the local oncology community are enabled via our IMED Core, and additional outreach programs to underrepresented minority students and industry are described. Finally, we describe our outreach to the global community via public data base sharing, publication, and public communication forums.
NSBCC教育与培训计划旨在将癌症研究人员与物理科学家和技术人员一起融合在一起,以加快与癌症作斗争的新工具的发展。我们的目标是让了解癌症生物学或临床肿瘤学问题的学生和博士后研究人员可以参与技术发明,开发和验证,然后可以证明技术在临床前环境中的价值,并希望通过人类参与 研究。我们描述了我们的各个项目中的一对一指导计划,旨在通过这种培训进行这种培训,但也促进了协作工作。我们还描述了在每个参与机构中教授的三门NSBCC短课程,这些课程旨在教我们研究人员与NSBCC开发的技术以及NSBCC正在进行的项目相关的关键基本方面。 这些课程是为非专家设计的,与参与机构提供的更多专业学生设计的深度课程相辅相成。我们还描述了内部教育活动,包括学生和博士后参加我们的年度务虚会,每两周一次的NSBCC项目会议,现场审查和全国CCNE会议。促进内部和频率间协作的机制。教育计划由我们的内部审查理事会监督,并每年由我们的外部顾问委员会进行审查。启用了向当地肿瘤学社区推出计划 通过我们的IMED核心,描述了代表不足的少数族裔学生和行业的其他外展计划。最后,我们通过公共数据库共享,出版物和公共传播论坛描述了我们对全球社区的宣传。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James R. Heath其他文献

Protein Catalyzed Capture (PCC) Agents for Antigen Targeting.
用于抗原靶向的蛋白质催化捕获 (PCC) 试剂。
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Idso;B. Lai;Heather D Agnew;James R. Heath
  • 通讯作者:
    James R. Heath
Planar Patch-Clamp Electrodes for Single Cell and Neural Network Studies
  • DOI:
    10.1016/j.bpj.2009.12.3287
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    John M. Nagarah;Daniel A. Wagenaar;James R. Heath
  • 通讯作者:
    James R. Heath
Stereochemical engineering of a peptide macrocycle allosteric inhibitor of phospho-Akt2 controls cell penetration by fine-tuning macrocycle-cell membrane interactions
磷酸 Akt2 肽大环变构抑制剂的立体化学工程通过微调大环 - 细胞膜相互作用来控制细胞渗透
  • DOI:
    10.26434/chemrxiv-2021-kldh7
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Arundhati Nag;A. Mafi;Samir R Das;Mary Beth Yu;Belen Alvarez;W. Goddard;James R. Heath
  • 通讯作者:
    James R. Heath
Calcium and Photoentrainment in Chick Pineal Cells Revisited: Effects of Caffeine, Thapsigargin, EGTA, and Light on the Melatonin Rhythm
重新审视小鸡松果体细胞中的钙和光夹带:咖啡因、毒胡萝卜素、EGTA 和光对褪黑激素节律的影响
  • DOI:
    10.1046/j.1471-4159.1995.65031332.x
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    M. Zatz;James R. Heath
  • 通讯作者:
    James R. Heath
Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis.
可生物降解的无水氨苄青霉素微胶囊局部治疗实验性葡萄球菌骨髓炎的评价。

James R. Heath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James R. Heath', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10526102
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
用于指导序贯靶向抑制剂的时空肿瘤分析:免疫治疗组合(ST-Analytics)
  • 批准号:
    10708901
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
  • 批准号:
    10907268
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
用于指导序贯靶向抑制剂的时空肿瘤分析:免疫治疗组合(ST-Analytics)
  • 批准号:
    10526101
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
  • 批准号:
    10526103
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10708920
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
  • 批准号:
    10708924
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction
用于免疫治疗反应预测的数据驱动的基于患者特异性药物的转移性黑色素瘤模型
  • 批准号:
    10831325
  • 财政年份:
    2022
  • 资助金额:
    $ 5.32万
  • 项目类别:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
用于新抗原特异性 T 细胞捕获和表征的纳米和生物分子工程技术
  • 批准号:
    10297588
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
用于新抗原特异性 T 细胞捕获和表征的纳米和生物分子工程技术
  • 批准号:
    10489832
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:

相似海外基金

Germline risk of oral and oropharyngeal cancers across diverse populations
不同人群患口腔癌和口咽癌的种系风险
  • 批准号:
    10302988
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
Germline risk of oral and oropharyngeal cancers across diverse populations
不同人群患口腔癌和口咽癌的种系风险
  • 批准号:
    10456323
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
EBV特异性T细胞在EBV驱动的鼻咽癌检查点阻断免疫治疗中的作用
  • 批准号:
    10681300
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
EBV特异性T细胞在EBV驱动的鼻咽癌检查点阻断免疫治疗中的作用
  • 批准号:
    10281126
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
EBV特异性T细胞在EBV驱动的鼻咽癌检查点阻断免疫治疗中的作用
  • 批准号:
    10457484
  • 财政年份:
    2021
  • 资助金额:
    $ 5.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了